Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jan 15, 2015 21:10:09 GMT -5
And it has been sitting on this range for about a while now probably for a quarter.... whats stopping BAC to buy the stock in open market and end it? Its not like the daily volume is 1000 shares.. avg daily volume is 4 million Daily volume may be high but getting 9 million real shares could be hard. I wouldn't be surprised if the vast majority of the shares traded are ghost shares or the same shares going back and forth. Buying 9 million real shares could destabilize the current price structure (which could be very good for us obviously...). JPG I dont agree that getting 9 million shares are hard.. from yahoo finance : Total shares traded from 10-Oct 2014 to yesterday : 305,923,500Avg Price : 5.67 9 million shares is 3%? |
|
|
|
Post by jpg on Jan 15, 2015 21:32:10 GMT -5
Daily volume may be high but getting 9 million real shares could be hard. I wouldn't be surprised if the vast majority of the shares traded are ghost shares or the same shares going back and forth. Buying 9 million real shares could destabilize the current price structure (which could be very good for us obviously...). JPG I dont agree that getting 9 million shares are hard.. from yahoo finance : Total shares traded from 10-Oct 2014 to yesterday : 305,923,500Avg Price : 5.67 9 million shares is 3%? Trade the same 1 million shares 305.9235 times and you have your volume since 10-10-14. If you don't agree these same share (and sometimes no shares) are bought and sold 10-20 or even 100 times per day then we are not reading the same algo information. The way the system works (to the benefit of algo traders and exchages who get commisions) there is, as far as I know, no way of knowing how many shares are new or old (ie 'recycled') or even ghost shares (naked short then 'naked buy'). The vast majority of trades are not done by humans and especially so in biotech. The average time a share is owned about 20 seconds or so. www.telegraph.co.uk/finance/personalfinance/investing/9021946/How-long-does-the-average-share-holding-last-Just-22-seconds.htmlDo you really think the is all new shares being traded? If so where are the coming from? Look at the requirements for institutions, insiders etc... Mannkind (and many other companies have illusionary volume. NASDAQ has mostly bots for clients. We 'long term retail holders' are the pray. The more we collectively understand this the less vulnerable we become. Stop loses are just the simplest manifestation of this. The big one are options where we have an extraordinarily asymmetrical access to information. JPG |
|
|
|
Post by purge on Jan 16, 2015 9:42:54 GMT -5
I have been asking forever if we know how many of the shares traded on a daily volume are churned shares.
|
|
|
|
No Respect
Jan 16, 2015 10:50:24 GMT -5
via mobile
Post by jpg on Jan 16, 2015 10:50:24 GMT -5
I have been asking forever if we know how many of the shares traded on a daily volume are churned shares. Market makers and exchanges sadly have little or no incentive to give this information. Another asymmetrical advantage for market makers and those who have powerful computer tech. |
|
|
|
Post by spiro on Jan 16, 2015 14:45:35 GMT -5
I swear to the Greek Gods that Spiro did not write this post on the YMB. But I am jealous.
i_am_ultron • 2 hours 25 minutes ago
HERE IS WHY TECHNOSPHERE IS THE HOLY GRAIL....AFREZZA IS THE ATTENTION GRABBER
1. Any big bio can extend the patent on their product by reformulating to dry power inhalation extending its life and profitability.
2. Since dry power inhalation is delivered to the lung and immediately absorbed into the bloodstream the medicine avoids the stomach and liver which would greatly diminish the potentcy of the drug. Big bio can use less product for the same effect greatly increasing their profit margins.
3. I agree with Kevin.........some kind of restructure is in the cards here. MNKD will eventually sell Afrezza to SNY and retain and license technospere to many companies. That's the money machine. The cash will roll in and MNKD will spend nothing. MNKD want the predictability of ongoing cash flows.
4. No one has ever commented here on who produces the dreamboat and cricket delivery devices. I don't know who it is but its possible that Medtronic will surely be in the mix here someway.
We all have to be patient although mine is wearing thin. The silence is very painful but one has to believe its done for a reason which could be for strategic reasons. If not for that then this is an arrogant company that does not give a damn about the outside shareholders. Al has always said he expects at least a 10 X's return on his investments. So, why should now be any different? Al has always created products that enhanced the lives of millions.............but he did not do it for nothing. He got very rich..........its my turn.........holding 105,200 shares and waiting. Less
|
|
|
|
Post by ashiwi on Jan 16, 2015 15:26:02 GMT -5
Are you jealous because you didn't write this post and you wish you did... or are you jealous because you don't have 105,200 shares? or do you?  |
|
|
|
Post by spiro on Jan 16, 2015 15:57:53 GMT -5
Both, but more jealous of the 105,200. Dang it
|
|
|
|
Post by dreamboatcruise on Jan 16, 2015 16:46:37 GMT -5
I swear to the Greek Gods that Spiro did not write this post on the YMB. But I am jealous. i_am_ultron • 2 hours 25 minutes ago 1. Any big bio can extend the patent on their product by reformulating to dry power inhalation extending its life and profitability. 4. No one has ever commented here on who produces the dreamboat and cricket delivery devices. I don't know who it is but its possible that Medtronic will surely be in the mix here someway. Al has always said he expects at least a 10 X's return on his investments. So, why should now be any different? Perhaps this lizard is just green with envy over 105k share ownership, and thus picking nits but a few comments... 1. Don't we know that Afrezza actually requires MORE insulin than would an equivalent injection? Perhaps there are some drugs for which ultron's assumption would be true, but based on Afrezza it would seem that it may well not be true. 4. How on earth is Medtronic "surely" in the mix. Medtronic's core competencies would seem to have little to do with technosphere platform. I'm sure the design work and testing of dreamboat has impressive, but the production of it could be done by a myriad of companies supplying consumable plastic parts for medical applications. Yes, technically it is a "device" but it is not the type of device Medtronic makes. Even on the marketing side of things, Medtronic doesn't have a sales force that would be useful for the types of things likely in the technosphere pipeline. Why are people fixated on Medtronic? Does Medtronic have a whistle manufacturing business I'm unaware of? Why would now be diferent?... because when he last said that it was before a HUGE amount of dilution. No previous Mann company has suffered this type of setbacks and dilution. The market cap may well end up being ten times when it first went public, but that doesn't mean the share price will be. |
|
|
|
Post by jpg on Jan 16, 2015 18:23:45 GMT -5
I swear to the Greek Gods that Spiro did not write this post on the YMB. But I am jealous. i_am_ultron • 2 hours 25 minutes ago 1. Any big bio can extend the patent on their product by reformulating to dry power inhalation extending its life and profitability. 4. No one has ever commented here on who produces the dreamboat and cricket delivery devices. I don't know who it is but its possible that Medtronic will surely be in the mix here someway. Al has always said he expects at least a 10 X's return on his investments. So, why should now be any different? Perhaps this lizard is just green with envy over 105k share ownership, and thus picking nits but a few comments... 1. Don't we know that Afrezza actually requires MORE insulin than would an equivalent injection? Perhaps there are some drugs for which ultron's assumption would be true, but based on Afrezza it would seem that it may well not be true. 4. How on earth is Medtronic "surely" in the mix. Medtronic's core competencies would seem to have little to do with technosphere platform. I'm sure the design work and testing of dreamboat has impressive, but the production of it could be done by a myriad of companies supplying consumable plastic parts for medical applications. Yes, technically it is a "device" but it is not the type of device Medtronic makes. Even on the marketing side of things, Medtronic doesn't have a sales force that would be useful for the types of things likely in the technosphere pipeline. Why are people fixated on Medtronic? Does Medtronic have a whistle manufacturing business I'm unaware of? Why would now be diferent?... because when he last said that it was before a HUGE amount of dilution. No previous Mann company has suffered this type of setbacks and dilution. The market cap may well end up being ten times when it first went public, but that doesn't mean the share price will be. For # 1 what he is probably saying is that biologicals (and non biologicals) going off patent or off patent could be reformulated in inhaled form and given a new life. biologicals would therefor not need to be injected and pills would work a lot faster. For #4 and Medtronic I completely agree as I can't see why medtronic needs to be in the mix just to build a little cheap piece of molded plastic. Maybe Medtronic is really interested but that just doesn't make a lot of sense to me. JPG |
|
|
|
Post by dreamboatcruise on Jan 16, 2015 19:33:52 GMT -5
Ooops... I incorrectly copied #1. It was #2 I was commenting on. I'm skeptical as to whether their is cost savings because less drug compound would be needed. Sorry for confusion.
|
|
|
|
Post by jpg on Jan 16, 2015 19:40:06 GMT -5
Ooops... I incorrectly copied #1. It was #2 I was commenting on. I'm skeptical as to whether their is cost savings because less drug compound would be needed. Sorry for confusion. Agreed but then again I am skeptical that a lot of these biologicals cost as much to make as they say they cost... Including insulin. I agree with Sanofiand MNKD that costs of insulin could be meaningfully reduced. JPG |
|
|
|
Post by babaoriley on Jan 17, 2015 0:29:03 GMT -5
Both, but more jealous of the 105,200. Dang it Wait a minute, wait a minute. There are people who are allowed to post on this board with fewer than 100,000 shares? Oh, my, now that is an issue. Just who in the heck have I been listening to for so long here! When I signed up, I'm pretty sure Liane assured me this Board was reserved for people of substance only. Could she have meant "substance abusers?" I can tolerate people "reading" or "auditing" the Board with fewer shares, but posting? Really? I mean, if you're under six figures in shares, do you even have a genuine interest in the company? Why would you even bother to post, how meaningful could this be to you? Okay, if you're diabetic, I can understand your interest, but if you've only got 75,000 shares, well, it's better to be seen and not heard. I think you should be able to hit the "like" button, but it stops there. Have I been corresponding with the have nots, the hoi polloi, the unwashed? I guess I assumed everyone here was retired or just worked cuz they were fond of it or just trying to have some time away from their spouse! Does this mean Spiro doesn't have a 120 foot yacht on which he cruises and posts from the Caribbean? Have I been misled? And he talks about meeting in Vegas at his favorite hotel upon success with MNKD - I assumed all along he was at least part owner. I suppose it's too late to kick people off who can't provide evidence of owning over 100,000 shares, but, perhaps, if it were made a rule that you had to include the number of shares you actually hold in your handle, well, then, at least we'd know who's posts we could, well, you know, ....skim or maybe read while driving. Now that Spiro is a Global Chieftain or whatever of this Board, I assume he won't support such a change, but surely Liane and Brentie will, after all, "cat people" are known to be wealthy and eccentric - my guess is those darn cats probably stand to inherit more MNKD stock than even JPG has! And mannmade will certainly back me up, in fact, if he's reading this, he's probably just as aghast as I about this whole business. Am I now going to find out that Lynn and Coco are also casual investors? Well, I should have suspected it, cuz when we went to lunch, Lynn seemed confused as to the use of the napkin, and Coco kept looking around for a counter from which to order, and then shared her surprise when she discovered our waitress was not wearing roller skates. Also, they kept asking for additional silverware, although I didn't notice either of them drop any, and they only infrequently used their forks. This has been an unpleasantly enlightening evening. I shall retire to my bed chamber shortly with my brandy and cigar to mull the future. |
|
|
|
Post by spiro on Jan 17, 2015 8:58:56 GMT -5
Baba, I apologize if I have misled you. I am just a poor old Greek with a big dream. Therefore I will allow you to pick the tab when we celebrate in Vegas. Don't believe that old saying that the Greek rich get richer and the poor Greeks get poorer. It's the smart Greeks get richer and the dumb Greeks get poorer. At times this Greek has been a little more dumb than smart, but that will soon be changing. BTW, the only people I know that have over 105,000 shares of MNKD would be Ashiwi and Rak666.
|
|
